Try it
Pharmacology · Antibacterials: daptomycin limitation
Sample itemA patient on a ventilator has MRSA-positive ventilator-associated pneumonia. The team considers using daptomycin because the organism is susceptible in vitro. Why is it unsuitable in this infection?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. It is inactivated by pulmonary surfactant, so it is ineffective for pneumonia
Daptomycin is a lipopeptide that depolarises Gram-positive bacterial membranes in a calcium-dependent manner and is rapidly bactericidal, useful for MRSA bacteraemia and skin infection. Pulmonary surfactant binds and inactivates it, so it must not be used for pneumonia. Linezolid or vancomycin are used for MRSA pneumonia, and creatine kinase should be monitored with daptomycin.
Option by option
A. It is inactivated by pulmonary surfactant, so it is ineffective for pneumonia (correct)
Correct. Surfactant binding makes daptomycin ineffective in the lung.
B. It lacks bactericidal action against Gram-positive cocci
Daptomycin is rapidly bactericidal against Gram-positive cocci.
C. It is not absorbed after intravenous infusion
It is given intravenously, so absorption is not an issue.
D. It is not active against MRSA
Daptomycin is active against MRSA, which is why it was considered.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?